BR0115215A - Método para o tratamento de inflamações - Google Patents
Método para o tratamento de inflamaçõesInfo
- Publication number
- BR0115215A BR0115215A BR0115215-7A BR0115215A BR0115215A BR 0115215 A BR0115215 A BR 0115215A BR 0115215 A BR0115215 A BR 0115215A BR 0115215 A BR0115215 A BR 0115215A
- Authority
- BR
- Brazil
- Prior art keywords
- skin
- mucous membrane
- treating inflammation
- dimethicone
- inflammation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
"MéTODO PARA O TRATAMENTO DE INFLAMAçõES". Um método para tratar, eliminar e prevenir uma inflamação da pele ou membrana mucosa de um mamífero, inclusive de um ser humano, pela administração na pele ou membrana mucosa de uma composição que contém dimeticona e um transportador farmaceuticamente aceitável. A composição de dimeticona é aplicada à pele ou membrana mucosa em uma quantidade eficaz para tratar, eliminar ou prevenir a inflamação.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24679200P | 2000-11-08 | 2000-11-08 | |
PCT/IB2001/002096 WO2002038160A1 (en) | 2000-11-08 | 2001-11-08 | Method for the treatment of inflammation |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0115215A true BR0115215A (pt) | 2003-12-30 |
Family
ID=22932223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0115215-7A BR0115215A (pt) | 2000-11-08 | 2001-11-08 | Método para o tratamento de inflamações |
Country Status (11)
Country | Link |
---|---|
US (1) | US20050101632A1 (pt) |
EP (1) | EP1333839A1 (pt) |
JP (1) | JP2004513149A (pt) |
CN (1) | CN1561220A (pt) |
AU (1) | AU2002212606A1 (pt) |
BR (1) | BR0115215A (pt) |
CA (1) | CA2428164A1 (pt) |
IL (1) | IL155769A0 (pt) |
MA (1) | MA25852A1 (pt) |
MX (1) | MXPA03004017A (pt) |
WO (1) | WO2002038160A1 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2534603T3 (es) * | 2004-06-30 | 2015-04-24 | E-L Management Corp. | Composiciones cosméticas y procedimientos que comprenden Rhodiola Rosea |
DE102005009515A1 (de) * | 2005-02-25 | 2006-09-07 | Exner, Heinrich, Dr. | Verfahren zur Herstellung einer Zubereitung einer DMSO-haltigen festen Silikonölemulsion zur Bindung von reaktiven Sauerstoffverbindungen im Körper von Menschen und Tieren |
DE102007007698A1 (de) | 2007-02-09 | 2008-08-21 | Exner, Heinrich, Dr. | Verwendung einer hochemulgierten Silikonöl-Emulsion (HSE)zur Herstellung eines Medikamentes |
WO2009082511A1 (en) * | 2007-12-20 | 2009-07-02 | Elc Management Llc | Methods and compositions for treating skin |
US9687517B2 (en) | 2007-12-20 | 2017-06-27 | Elc Management Llc | Methods and compositions for treating skin |
US20100099766A1 (en) * | 2008-10-16 | 2010-04-22 | Novartis Ag | Topical NSAID compositions having sensate component |
US20110237674A1 (en) * | 2008-10-16 | 2011-09-29 | Novartis Ag | Topical nsaid compositions having sensate component |
WO2012057895A2 (en) | 2010-10-26 | 2012-05-03 | Quinnova Pharmaceuticals, Inc. | Composition and method for treating wounds |
PL2726092T3 (pl) | 2011-06-28 | 2019-11-29 | Inhibrx Lp | Polipeptydy fuzyjne serpiny i sposoby ich stosowania |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR175F (pt) * | 1964-05-25 | 1900-01-01 | ||
US4847069A (en) * | 1987-10-22 | 1989-07-11 | The Procter & Gamble Company | Photoprotection compositions comprising sorbohydroxamic acid and an anti-inflammatory agent |
US5888523A (en) * | 1997-09-22 | 1999-03-30 | Biocontrol, Inc. | Topical non-steroidal anti-inflammatory drug composition |
US6262020B1 (en) * | 2000-02-15 | 2001-07-17 | Alphamed Pharmaceuticals Corp. | Topical wound therapeutic compositions |
-
2001
- 2001-11-08 MX MXPA03004017A patent/MXPA03004017A/es unknown
- 2001-11-08 WO PCT/IB2001/002096 patent/WO2002038160A1/en not_active Application Discontinuation
- 2001-11-08 CN CNA018197442A patent/CN1561220A/zh active Pending
- 2001-11-08 CA CA002428164A patent/CA2428164A1/en not_active Abandoned
- 2001-11-08 EP EP01980821A patent/EP1333839A1/en not_active Withdrawn
- 2001-11-08 US US10/415,793 patent/US20050101632A1/en not_active Abandoned
- 2001-11-08 IL IL15576901A patent/IL155769A0/xx unknown
- 2001-11-08 BR BR0115215-7A patent/BR0115215A/pt not_active IP Right Cessation
- 2001-11-08 JP JP2002540743A patent/JP2004513149A/ja not_active Withdrawn
- 2001-11-08 AU AU2002212606A patent/AU2002212606A1/en not_active Abandoned
-
2003
- 2003-05-05 MA MA27140A patent/MA25852A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
AU2002212606A1 (en) | 2002-05-21 |
MXPA03004017A (es) | 2004-02-12 |
JP2004513149A (ja) | 2004-04-30 |
WO2002038160A1 (en) | 2002-05-16 |
US20050101632A1 (en) | 2005-05-12 |
CN1561220A (zh) | 2005-01-05 |
MA25852A1 (fr) | 2003-07-01 |
EP1333839A1 (en) | 2003-08-13 |
CA2428164A1 (en) | 2002-05-16 |
IL155769A0 (en) | 2003-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0212142A (pt) | Método e sistema para tratamento de acne | |
BR9715022A (pt) | Método para tratar de doenças prostáticas usando formulações de vitamina d por liberação sistemática e/ou prolongada | |
ES2164916T3 (es) | Tratamiento de la esclerosis multiple. | |
BR0014996A (pt) | Método para prevenir ou melhorar a dor de um ferimento fechado cirurgicamente em um indivìduo, e, emplastro | |
BR0113447A (pt) | Método de tratamento ou prevenção do câncer em um ser humano, e, composição farmacêutica | |
BR0212252A (pt) | Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero | |
BR9916694A (pt) | Composição de lenço facial e método de uso parasequestração de irritantes cutâneos de secreçãonasal | |
BR9911076A (pt) | Uso de peg-ifn-alfa e ribavirina para o tratamento de hepatite c crÈnica | |
HU9700056D0 (en) | New pharmaceutical composition for treating pains | |
BRPI0011640B8 (pt) | ácidos aldônicos de oligossacarídeo e seu uso tópico | |
BR0309280A (pt) | Terapia de combinação para o tratamento de câncer | |
BR0115109A (pt) | Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese | |
KR960703009A (ko) | 중추유래의 수면성 무호흡증 및 호흡곤란증의 치료를 위한 모다피닐의 사용 | |
BR0211673A (pt) | Terapia dermal utilizando derivados de fosfato de agentes de transferência de elétrons | |
BR0313630A (pt) | Composição para aplicação tópica, sistema para o tratamento de caspa, métodos para o tratamento e/ou prevenção da caspa e da coceira do couro cabeludo e usos de uma combinação sinérgica | |
BR0010531A (pt) | Composições e usos de et743 para tratamento de câncer | |
DE69424777D1 (de) | 3,4-diarylchromane zur behandlung von dermatitis | |
BR0116293A (pt) | Composição tópica, e, método para prevenir, melhorar ou tratar a hiperpigmentação da pele | |
BR0115215A (pt) | Método para o tratamento de inflamações | |
BR0214075A (pt) | Dosagem unitária que compreende um análogo de prostaglandina para tratar constipação | |
BR0008443A (pt) | Inibidores de aminotransferaseaminoácido-dependente de cadeia ramificada e seuuso no tratamento da retinopatia diabética | |
BR0201974A (pt) | Composição farmacêutica para tratamento de alterações do sono | |
ES2136167T3 (es) | Composiciones de idebenona para tratar la enfermedad de alzheimer. | |
HK1037980A1 (en) | Use of selegiline or desmethylselegiline for the manufacture of a medicament for treating wounds, burns or photodamage. | |
ES2104223T3 (es) | 2-((2-(n-isobutil-n-metil)amino)-bencilsulfinil)bencimidazol como agente antimicrobiano contra helicobacter pylori. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 1964 DE 26/08/2008 E CONSIDERANDO A AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS. |